Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
株式のランク #12610
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
株価
$1.29
時価総額
$567.34M
変化(1日)
-1.33%
変化(1年)
-20.72%
CN
取引 Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

カテゴリー

Zhejiang Starry Pharmaceutical Co.,Ltd.(603520)の配当利回りの履歴
Zhejiang Starry Pharmaceutical Co.,Ltd.(銘柄コード: 603520)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Zhejiang Starry Pharmaceutical Co.,Ltd.(603520)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)